2004. Celecoxib and rofecoxib: efficacy and safety of selective inhibitors of Cox-2 compared to non-selective NSAIDs. Portuguese Journal of Family Medicine and General Practice. 20, 1 (Jan. 2004), 47–64. DOI:https://doi.org/10.32385/rpmgf.v20i1.10008.